Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Operating Margin
Lepu Medical Technology Beijing Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
22.4B CNY |
15%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.8B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
149.2B USD |
18%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142.4B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.6B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.6B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.1B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42.3B USD |
27%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
284.2B CNY |
36%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.4B USD |
13%
|
Lepu Medical Technology Beijing Co Ltd
Glance View
Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Lepu Medical Technology Beijing Co Ltd's most recent financial statements, the company has Operating Margin of 15.3%.
You don't have any saved screeners yet